(a) — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16… · Lexiara

(a)

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

adverse events or laboratory anomalies that are critical to safety evaluations and must be reported by the investigator to the sponsor, and

← anx_I__cpt_4__point_19__text_1 · All articles · anx_I__cpt_4__point_19__point_a__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.